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Recent experiments have identified a new H-2- like cell-surface glycoprotein which
is determined by the D region of the murine major histocompatibility complex. This
product, designated L (previously called D~ (1), is distinct from the K and D
molecules which bear the H-2 private specificities detected by cocapping (2) and
immunoprecipitation (3) techniques. Because D and L are encoded by genes which
have yet to be separated by recombination, both remain markers for the D region.
However, it was shown that a mutant mouse strain, BALB/c-H-2db (4), had lost the
L (but not the D) antigenic specificities from the cell surface (1, 5) . In studies of the
BALB/c-H-2db strain and the coisogenic strain BALB/c, it was demonstrated that H-
2L alloantigens elicit rapid skin graft rejection (4) and a strong primary in vitro
cytotoxic T-cell response (6). Therefore, H-2L products appear to function as major
transplantation antigens.
Blanden et al. (7) have recently reported that BALB/c-H-2db mice, in contrast to
wild-type BALB/c, failed to generate a T-cell response to ectromelia virus in associ-
ationwith products of the Dregion, whereas BALB/c-H-2db ectromelia-infected-target
cells could be lysed by D region-compatible ectromelia-immune T cells. The absence
of H-2L gene products was thus accompanied by a failure of stimulation, but not of
recognition at the level of cytotoxic effector function. This situation does not apply
for reactivity to minor transplantation antigens (7) or to trinitrophenol (TNP),t, z and
is unique for all the H-2 mutant strains employed in previous virus studies (8-10) .
The present study investigates: (a) whether the requirement for H-2L specificities in
stimulation of ectromelia virus-immune T cells specific for D region products is
unique, or also applies to other viruses; and (b) whether virus-immune T cells
recognize viral determinants in association with H-2L as well as H-2D gene products.
Materials and Methods
Mice.
￿
BALB/c-H-2db and BALB/ckh (H-2d) mice were bred from stock which was kindly
provided by Doctors Henry Kohn and Roger Melvold (Harvard Medical School and Shields
" Supported in part by U. S. Public Health Service grants CA-09140, AI-14162, and NS-11036; and by
grant 851-A-4 from the National Multiple Sclerosis Society.
$ Present address: Immunology Branch, National Cancer Institute, National Institutes of Health,
Bethesda, Md. Recipient of U. S. Public Health Service postdoctoral research award 1 F32 AI05812-01.
§ Recipient of U. S. Public Health Service postdoctoral research award 5 F32 CA05270-02.
11 Recipient of U. S. Public Health Service postdoctoral research award F32 CA05551-01 .
'Abbreviations used in this paper: SDS, sodium dodecyl sulfate; TNP, trinitrophenyl .
2 R. B. Levy, G. M. Shearer, andT. H. Hansen. 1978. Properties of H-2L locus products in allogeneic
and H-2restricted, trinitrophenyl-specific cytotoxic responses.J. Immunol. In press.
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Warren Lab, Boston, Mass.) . BALB.K (H-2k) mice were a gift from Dr. Kenneth Blank (Wis-
tar Institute, Philadelphia, Penn.) . D2.GD(H-2g2), A.TH(H-2+2), C3H.OH(H-2°2), and
C3H.OL(H-2o') were bred at the National Institutes of Health. B10.BR(H--2k) were purchased
from The Jackson Laboratory, Bar Harbor, Maine.
Viruses and Immunizations. The influenza type A viruses HK[A/Hong Kong/8/68-X-
31(H3N2)] and PR8[A/Puerto Rico/8/34(HONI)] were supplied and grown in embryonated
eggs as previously described (11) . Mice were immunized in vivo by intraperitoneal inoculation
with 200-300 hemagglutination units of virus in alloantoic fluid and spleen cells obtained 5
days later for assay. In vitro induction of secondary influenza-immune T cells was performed
by incubation of spleen cells from 4 to 16 wk-primed mice with influenza virus (2-4 HAU/10'
cells, 37°C, 1 h) and culturing for 5 days in RPMI-1640 medium supplemented with 10%
vol/vol fetal bovine serum, 0.01 mM nonessential amino acids, 0.1 mM sodium pyruvate, 0.03%
glutamine, 100 U/ml penicillin, and 100 hg/ml streptomycin (Grand Island Biologicals, Grand
Island, N. Y.).
The WR strain of vaccinia virus (obtained from Dr. R. M. Zinkernagel, Scripps Clinic and
Research Foundation, La Jolla, Calif) was grown in mouse L cells as described by Joklik (12).
Mice were immunized by intravenous inoculation of5 X 106 plaque-forming units of virus and
spleen cells harvested 6 days later for assay.
Target Cells and Cytotoxicity Assays.
￿
L cells (C3H, H-2k), P815 mastocytoma cells (DBA/2, H-
2d), NA neuroblastoma cells (A/J, H-2°), and B10.A(5R) SV, an SV40 virus-transformed cell
line ofkidney fibroblasts from B10.A(5R) (H-2`) mice, respectively, (obtained from Dr. Barbara
Knowles, Wistar Institute, Philadelphia, Penn.), were maintained in tissue culture. Lipopoly-
saccharide (LPS)-induced splenic lymphoblasts were prepared, labeled with b'Cr, and infected
with influenza virus as described by Zweerink et al. (13). Influenza virus infection of 6'Cr-
labeled tumor target cells was performed as described by Effros et al. (11) and vaccinia virus
infection according to Doherty et al. (14). Results of cytotoxicity assays are reported as mean
percent specific lysis of quadruplicate or triplicate determinations (11) .
Immunoprecipitation Analyses.
￿
Radiolabeling, solubilization, precipitation, and sodium dode-
cyl sulfate (SDS)-polyacrylamide gel electrophoresis were all performed by previously described
methods (15).
Alloimmunizations. Alloantisera were raised by primary immunization with a skin graft
followed by weekly injections of 2 X 107 live lymphoid cells. The titer was assessed in a two-
stage microcytotoxicity assay using rabbit serum as a source of complement (16). Anti-D
antiserum [(B10.AKM X A.BY) anti-A.AL)] and anti-L antiserum (BALB/c-H-2db anti-
BALB/c) had titers on BALB/c cells of 1 :512 and 1 :128, respectively. These alloantisera detect
specificities on two distinct cell-surface glycoproteins as revealed by immunoprecipitation
analysis (Fig. 1).
Alloimmune cytotoxic T cells were generated by 5-day in vitro sensitization as previously
described (6) .
Results
BALB/c-H-2db and various control strains of mice were inoculated with influenza
or vaccinia viruses and their spleen cells were assayed for cytotoxic activity against
virus-infected K and/or D region-compatible target cells. No absolute discrimination
was seen in the capacity of influenza- or vaccinia-specific BALB/c and BALB/c-H-
2db
lymphocytes to mediate lysis of virus-infected D region-compatible NA (Kk-Dd)
or BIO.A(5R) (Kb-Dd) target cells (Tables I and II). The vaccinia-immune T-cell
populations from BALB/c-H-2db mice tended to be less effective, but there was no
evidence of a total failure of responsiveness (Table II) . In addition, secondary
influenza-immune BALB/c-H-2db T-cells generated by in vitro immunization of
primed spleen cells were also able to specifically lyse D region-compatible A.TH virus-
infected lymphoblasts (Table III) . These results imply that Lantigens are not required
for the generation of D region-restricted influenza- and vaccinia-immune T cells.
To determine if H-2L gene products are recognized by virus-immune T cells, anti-1680
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FIG. 1 .
￿
Electrophoretic patterns ofBALB/c antigen sequentially precipitated with antisera against
the D and L molecules. [sH]leucine-labeled antigen was pretreated by precipitation with the reagent
indicated on the left and the supernates from this first precipitation step were then tested for residual
reactivity with the reagent indicated above the panels.The test precipitates were solubilized with
SDS and subjected to disk electrophoresis on 10% polyacrylamide gels. Using this system, H-2
molecules (45,000 mol wt) migrate to a4 cm and a nonspecific running front appears at 8 cm of gel.
The top two panels indicate that both the anti-D and the anti-L serum precipitate BALB/c
molecules with an apparent mol wt of 45,000 daltons. The middle two panels show that although
pretreatment with antiserum to L completely removed L molecules (panel IV) the molecules
detected by the anti-D serum were unaffected (compare panels I and III) . Reciprocally, when the
molecules detected by the anti-D serum were removed (panels V and VI), the molecules detected by
the anti-L were unaffected (compare panels II and VI). Therefore, these results demonstrate that
the anti-L (BALB/c-H-2°° anti-BALB/c) and the anti-D (anti-H-2.4) react with independent
populations ofmolecules.BIDDISON, HANSEN, LEVY, AND DOHERTY
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TABLE I
Cytotoxic Activity Against Influenza Virus-Infected Cells
* Target cells were either infected with HK influenza virus or uninfected (N). SEM was always <10% of
the mean. Cytotoxicity assays were run for 12 h.
$ Letters in parenthesis indicate H-2K and D region haplotypes of target cells.
L and anti-D alloantisera were tested for their ability to block the lysis of D region-
compatible virus-infected NA (Kk-D d) target cells by BALB/c and BALB/c-H-2db
influenza-immune T cells. The results in Table IV show that anti-L alloantiserum
was consistently able to produce significant inhibition of cytotoxicity mediated by
virus-immune T cells from BALB/c, but not BALB/c-H-2db. The specificity of the
inhibiting effect of anti-L alloantiserum was shown by its ability to block alloimmune
effector cell activity directed against L antigens and the inability of this serum to
block the activity of alloimmune effector cells sensitized to D antigens. Anti-D
alloantiserum inhibited virus-immune cytotoxicity of both BALB/c and BALB/c-H-
2db T cells, but did not inhibit the activity of effeccoos directed against L alloantigens
on the NA target cells.
Discussion
Although BALB/c-H-2d6 mice do not display detectable cell-surface H-2L gene
products, they are able to generate influenza- and vaccinia-immune cytotoxic T-cells
which lyse D region-compatible Trget cells. However, these mice apparently do not
make a similar response to ectromelia virus (7) . These observations are particularly
interesting because vaccinia- and ectromelia-immune cytotoxic T-cell responses are
highly cross-reactive (17) . Furthermore, these two pox viruses share many serologically
defined determinants, detected by both virus neutralization and immunoprecipitation
in gels (18, 19). Relatively minor differences between two very similar viruses, together
with the presence or absence of a particular H-2 determinant (L), may thus determine
Exp
no.
HK-immune
spleen
cells
Effector
cell:
target
cell
NA(kd)$
HK N
Percent-specific lysis
Bl6.A(5R)SV(bd)
HK N
of target cells*
L(kk)
HK N
P815(dd)
HK N
1 BALB/c 25 :1 10.7 0.9 11 .0 2.0 0.7 1.2 19.0 1.6
50:1 20.7 2.2 21 .1 2.6 3.7 1.9 27.2 1.7
100:1 35.8 3.4 30.0 1 .3 3.4 3.0 37.8 1.9
BALB/c-H-2d' 25:1 10.3 1 .9 11 .1 4.3 2.1 1 .4 15.7 1.3
50:1 18.5 3.8 15 .7 5.9 4.7 4.0 27.5 1.4
100:1 37.4 7.2 24.1 5.9 9.5 4.5 41 .6 2.0
BALB.K 25:1 32.3 1 .4 4.2 2.4 45.0 0.2 4.2 1.6
50:1 45.1 2.0 4.0 1.6 57.3 -0.1 4.6 1 .1
100:1 58.1 5.0 7.1 4.2 68.3 0.9 5.3 2.7
2 BALB/c 25:1 12.3 -1 .7 0 0.6 45.4 -0.1
50: L 23.2 -1.4 2.0 1 .7 66.2 -0.7
100:1 33.6 0.5 2.1 4.8 75.0 11.1
BALB/c-H-2d° 25:1 4.4 -0.6 -0.3 -1.8 28.6 3.3
50:1 11.8 -1.7 1 .7 -0.6 46.0 5.3
100:1 23.3 0.7 1 .3 1.5 65.0 1.2
BIO.BR 25 :1 33.1 -2.1 44.2 -2.4 -3.5 2.0
50:1 46.4 -1.6 56.1 -1 .0 -3.5 4.4
100:1 55.1 -0.7 59.7 0.9 0.3 0.81682
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' Target cells were infected with vaccinia virus (VAC) or uninfected (N). SEM was always <20% of the
mean. Cytotoxicity assays were run for 12 h.
TABLE III
Secondary Influenza-Immune Effector-Cell Activity on Virus-Infected H-2K or H-2D Region-Compatible
Lymphoblasts
TABLE II
Cytotoxic Activity Against Vaccinia Virus-Infected Cells
Target cells were LPS-induced splenic lymphoblasts. Cytotoxicity assay was run for 3 h.
$ Spleen cells from mice primed 7 wk previously with PR8 were restimulated in vitro with HK virus.
the extent to which an animal can respond. Perhaps this reflects a phenomenon
similar to that described for Friend leukemia virus by Bubbers et al. (20), where
presence or absence of a Cytotoxic T-cell response is correlated with whether or not a
particular H-2K or H-2D component is incorporated into the virus particle.
Antisera-blocking experiments indicated that BALB/c mice possess a subset of
Exp.
no.
Vaccinia-
immune
spleen
cells
Effector
cell:
target
cell
NA(kd)
VAC N
Percent-specific lysis
B10.A(5R)SV(bd)
VAC N
of target cells"
L(kk)
VAC N
P815(dd)
VAC N
1 BALB/c 25 :1 8.4 2.0 17.0 0.6 3.6 2.0 27.9 0.5
50:1 18.4 3.0 26.9 2.8 5.9 3.4 43.8 2.2
100:1 32.1 9.1 36.0 3.3 8.1 7.2 63.2 1.4
BALB/c-H-2d° 25:1 4.9 2.7 11 .0 3.6 3.4 2.1 21 .3 2.7
50:1 10.5 5.4 16.8 5.9 7.0 4.2 27.6 3.8
100:1 24.8 11.9 23.9 7.6 9.1 6.7 57.1 3.4
BALB.K 25:1 31.9 1.1 4.7 4.9 48.8 1.7 3.4 4.4
50:1 48.2 3.0 9.8 6.0 64.3 0.8 5.4 5.3
100:1 57.0 9.8 15.5 6.8 70.9 2.4 9.7 7.1
2 BALB/c 25:1 12.1 -0.1 16.7 -5.5 -4.0 1.4 30.9 -5.9
50:1 27.2 6.0 26.9 -4.7 0.3 6.2 36.3 -3.7
100:1 41 .1 13.6 38.4 -0.9 5.6 10.6 45.6 10.9
BALB/c-H-2d° 25:1 10.2 5.1 7.6 2.4 1 .5 5.6 28.1 4.8
50:1 18.9 10.5 17.1 6.0 5.6 9.9 41.6 4.0
100:1 39.0 16.1 25.0 8.0 15.0 14.9 46.3 15.6
B10.BR 25:1 30.5 3.0 0.9 1 .0 41 .2 3.6 7.4 7.6
50:1 41 .2 5.9 3.2 2.3 51 .7 8.7 11.9 13.9
100:1 50.7 17.5 8.2 9.1 61 .2 12.9 15.1 15.5
Effector
Percent-specific lysis t SEM of target cells"
HK-immune cell:
spleen D2.GD (db) A.TH (sd) B10.BR (kk)
cells$ target
cell HK N HK N HK N
BALB/c 1 :1 14.9 t 1.5 -0.2 ± 0.6 10.7 t 1.7 -2.5 ± 0.6 2.3 t 2.1 5.6 ± 3.4
5:1 27.8 ± 0.8 0.1 t 0.6 22.1 t 2.2 -0.6 ± 0.8 6.1 ± 2.8 8.7 t 2.5
20:1 37.0 ± 1.0 2.7 ± 0.7 35.3 ± 3.0 -1.2 ± 0.7 11 .1 ± 2.6 11.1 t 2.1
BALB/c-H-2d° 1 :1 19.2 ± 2.5 2.6 t 1.5 6.3 t 1 .8 1.1 t 0.6 1 .0 ± 3.2 1.6 ± 2.1
5:1 34.2 ± 1.1 1 .2 t 0.8 17.1 t 1 .7 2.3 ± 0.8 2.0 ± 2.7 3.6 t 2.4
20:1 38.0 ± 1.5 0.6 t 0.5 29.8 ± 3.1 2.1 ± 1.2 4.1 t 3.0 6.3 t 2.1
B10.BR 1 :1 -0.1±0.8 0.3±0.5 -3.4± 1 .7 -1.7±0.8 9.8±2.3 0.7 t 1.6
5:1 1.4 ± 0.8 1.3 ± 0.9 -2.3 t 1 .6 0.1 ± 0.9 23.7 ± 2.2 3.3 t 3.5
20:1 3.5 ± 0.7 4.4 ± 1.1 1 .5 ± 1 .6 3.9 ± 1.1 27.8 ± 2.3 0.9 ± 1.8TABLE IV
Ability ofAnti-H-2L Alloantisera to Block Influenza-Immune Cytotoxicity on D Region-Compatible Target
Cells
BIDDISON, HANSEN, LEVY, AND DOHERTY
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*
￿
10 id (Exp. 1) or 5 id (Exp. 2 and 3) of each serum were added to 10" target cells.
$ See Table III.
§ Percent specific lysis t SEM of triplicate determinations in a 3-4 h assay.
~~ P values determined by Student'sttest which compares experimental lysis relative to lysis in presence
of normal mouse serum.
Not determined.
** Effector cells are BALB/c-H-2d" anti-BALB/c.
$$ Effector cells are C3H.OL (Exp. 1 and 2) or C3H.OH (Exp. 3) anti-BALB/c-H-2d6.
influenza-immune T-cells which recognize H-2L gene products, and that products of
the H-2L locus can thus operate in an analogous manner to H-2K/D gene products
in virus-immune T-cell recognition. This conclusion is based on the specificity of the
anti-L alloantiserum used in this study. As shown by immunoprecipitation studies
(Fig. 1 and reference 21), the anti-L serum did not precipitate molecules which bear
the K or D region private specificities. The inability to block alloimmune T-cells
directed against H-2D alloantigens further confirmed the lack of anti-D reactivity in
the anti-L alloantiserum. Thus, the inhibitory effect of the antiserum is most likely
due to anti-L antibodies because ofthe specific inhibition of cytotoxicity and the lack
of reactivity with H-2D molecules by immunoprecipitation analysis. Although it
could be argued that the inhibitory effect of anti-L alloantiserum on virus-immune T
cells is due solely to a steric inhibition of H-2D specificites on the virus-infected target
Exp.
no.
HK-immune
effector cells$ None
Blocking
Normal
mouse
Antisera*
Anti-
H-2L
Anti-
H-2D
1 BALB/c 25.8 t 3.5§ 30.7 t 2.4 17.5 t 1 .1 13.8 t 1.6
P<0.0111 P<0.01
'u u
U BALB/c-H-2db 15.5 t 1.2 16.0 t 1.2 13.9 t 0.9 3.4 t 1.3
P>0.2 P<0.005 c
m 2 BALB/c 26.8 t 2.7 36.2 t 3.1 17.4 t 1.8 24.4 t 3.0
xz
P < 0.008 P < 0.05
BALB/c-H-2d° 15.0 t 1.2 21.6 f 2.6 17.9 t 2.1 9.0 t 2.3
P>0.3 P<0.03
3 BALB/c 29.8 t 1.5 31.6 t 1.9 13.5 t 1 .7 ndfl
P < 0.005
Alloimmune
effector cells
i Anti-H-2L** 31.1 t 2.6 29.4 t 2.7 11 .7 t 2.4 25.6 t 3.7
P < 0.01 P > 0.5
Anti-H-213$$ 18.9 t 1.3 12.3 t 3.2 12.0 t 1.1 -4.4 t 2.2
U P>0.9 P<0.005
V 2 Anti-H-2L 16.3 t 2.6 17.4 t 2.4 3.3 t 1.9 14.4 t 1.3 w c
Op P<0.02 P>0.3
]a
Anti-H-21) 25.7 t 2.1 34.2 t 6.1 29.4 t 3.1 2.2 t 2.0
z P>0.5 P<0.009
3 Anti-H-2L 24.7 t 2.8 22.1 t 2.0 5.2 t 1.2 nd
P < 0.01
Anti-H-2D 27.8 t 1 .2 23.7 t 2.5 22.3 t 1.6 nd
P > 0.51684
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cell membrane, the inability of anti-L to inhibit lysis mediated by virus-immune
BALB/c-H-2db T cells on these targets makes such an explanation untenable.
The results, which show that influenza- and vaccinia-immune BALB/c-H-2db mice
are able to lyse D region-compatible wild-type target cells, are in contrast to those
obtained using another D region mutant, B10.132-H-2 d" (22). Zinkernagel and Klein
(23) observed that lymphocytic choriomeningitis virus- and vaccinia virus-immune
B 10.D2-H-2da T cells were unable to kill D region-compatible wild-type targets, a
result which we have also observed with influenza virus (data not shown) . These
findings imply that B10.D2-H-2da, unlike BALB/c-H-2db, lack virus-immune T cells
which recognize both wild type L and D molecules. Consistent with this notion are
recent findings by McKenzie et al.3 which demonstrated that B10.D2-H-2da mice
possess mutations which affect both the L and D molecules.
Although influenza-immune T cells apparently recognize H-2L specificities, current
studies using the same alloantisera and mouse strains indicate that there is no H-2L-
restricted component in the T-cell response to trinitrophenyl (TNP)-modified cells.2
Blanden and Kees (24) recently reported that T cells generated against ectromelia
virus and minor histocompatibility antigens do not recognize H-2L specificities. Thus,
T cells appear to possess a more selective repertoire of responses associated with L
than with K or D antigens. The mechanisms which produce this selectivity of
responsiveness are not known, but an altered self model may most easily explain these
observations : the minimum requirement for the generation of H-2-restricted T-cell
responses is the physical association of foreign antigens with H-2K, D, or L-encoded
self structures. Because TNP most probably is covalently linked to L molecules, the
failure to demonstrate a TNP-specific H-2L-restricted T-cell response would seem to
argue against the concept that formation of an altered self structure is the only
requirement for generation of H-2-restricted cytotoxic responses. Perhaps this result
may be due to a failure to generate the H-2L-restricted anti-TNP repertoire during
differentiation in the thymus (25, 26) .
Summary
The H-2L locus is closely linked to H-2D and codes for antigenic specificities present
on a 45,000 mol wt glycoprotein that is distinct from the molecule which bears the D
region private specificity. It was found that BALB/c-H-2db mice, which lack detectable
cell-surface H-2L gene products, were able to generate influenza- and vaccinia-
immune cytotoxic T cells which lyse D region-compatible target cells, although they
have been reported to be incapable of making a similar response to ectromelia virus
(7) . Thus, the lack of H-2L antigenic specificities does not produce a general loss of
responsiveness for other viruses even when a highly cross-reactive pox virus (vaccinia)
was studied.
Antisera-blocking experiments utilizing sera specific for either L or D molecules
indicated that BALB/c mice generate influenza virus-immune cytotoxic T-cell subsets
which independently recognize H-2L and H-2D gene products in association with
viral antigens. These results are the first indication that products of the H-2L locus
can operate analogously to H-2K/D gene products in virus-immune T-cell recognition.
Receivedforpublication 21 August 1978.
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